Tokyo, Aug. 16 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062556) titled 'The Japan Surgical Unloading Renal Protection and Sustainable Support Study (SURPASS JP)' on Aug. 12.
Study Type:
Observational
Primary Sponsor:
Institute - ABIOMED, Inc. (Sponsor)
Condition:
Condition - Patients who receive Impella 5.5 support as standard of care
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To document quality performance measures assessing the post-market surgical performance and clinical management of patients supported with Impella 5.5, and to identify factors influencing treatment strategies for Impella 5.5
Basic objectives2 - Safety,Effic...